Edition:
United States

Ampio Pharmaceuticals Inc (AMPE.A)

AMPE.A on American Stock Exchange

0.60USD
22 Sep 2017
Change (% chg)

$0.00 (+0.00%)
Prev Close
$0.60
Open
$0.60
Day's High
$0.60
Day's Low
$0.58
Volume
21,870
Avg. Vol
76,885
52-wk High
$1.11
52-wk Low
$0.38

Latest Key Developments (Source: Significant Developments)

Ampio Pharmaceuticals appointed Thomas E. Chilcott, III, co's interim CFO, as CFO effective as of August 16, 2017.
Tuesday, 29 Aug 2017 05:16pm EDT 

Aug 29 (Reuters) - Ampio Pharmaceuticals Inc :Ampio Pharmaceuticals- co announced that it appointed Thomas E. Chilcott, III, company s interim CFO, as CFO effective as of August 16, 2017..  Full Article

Ampio injects first patient in final pivotal clinical trial for Ampion BLA
Thursday, 22 Jun 2017 08:30am EDT 

June 22 (Reuters) - Ampio Pharmaceuticals Inc ::Ampio injects first patient in final pivotal clinical trial for Ampion™ BLA.Ampio Pharmaceuticals Inc says initiates dosing in AP-003-C, Phase 3, single injection Ampion study.  Full Article

Bruce Terker reports 6.58 pct passive stake in Ampio Pharmaceuticals - SEC filing
Wednesday, 14 Jun 2017 03:20pm EDT 

June 14 (Reuters) - Bruce E. Terker::Bruce E. Terker reports 6.58 percent passive stake in Ampio Pharmaceuticals Inc as of June 7, 2017 - SEC filing.  Full Article

Ampio Pharmaceuticals announces pricing of registered direct offering
Friday, 2 Jun 2017 12:16pm EDT 

June 2 (Reuters) - Ampio Pharmaceuticals Inc ::Ampio Pharmaceuticals Inc announces pricing of registered direct offering.Entered securities purchase deal with investors for sale of about $6.3 million shares, warrants to purchase shares with exercise price $0.76 per share.Deal ‍to purchase shares of common stock with an exercise price of $0.76 per share, at a combined purchase price of $0.60 per shr​.  Full Article

Ampio Pharmaceuticals files for non-timely 10-Q
Thursday, 11 May 2017 04:13pm EDT 

May 11 (Reuters) - Ampio Pharmaceuticals Inc :Files for non-timely 10-Q - sec filing.Ampio Pharmaceuticals says intends to file form 10-Q as soon as practicable, but no later than May 15, 2017.  Full Article

Ampio Pharmaceuticals files for mixed shelf of up to $100 mln
Friday, 31 Mar 2017 05:44pm EDT 

Ampio Pharmaceuticals Inc : Files for mixed shelf of up to $100 million - sec filing .In addition, 5.0 million shares of co's common stock offered by the selling stockholder.  Full Article

Ampio receives guidance from the FDA
Monday, 27 Feb 2017 08:30am EST 

Ampio Pharmaceuticals Inc : Ampio receives guidance from the FDA and proposes a path for approval for single-injection ampion™ for the treatment of pain due to severe osteoarthritis of the knee . Says ampio has proposed a small pre-approval study, randomized 6 to 1 on patients with severe oak . Says study will be completed concurrently with preparation for biologicals licensing application (bla) submission .Says Ampio has requested expedited review/approval for this serious medical condition with an unmet medical need.  Full Article

Ampio says met with FDA for Ampion biological license
Thursday, 29 Sep 2016 02:50pm EDT 

Ampio Pharmaceuticals Inc: Ampio updates clinical and regulatory activity . Has met with CBER division of FDA to seek guidance on best path forward to obtain a biological license for Ampion .Reported completion of enrollment for AP-011 sudy to evaluate safety of single intra-articular injection of Ampion for basal thumb arthritis.  Full Article

Ampio Pharmaceuticals announces pricing of registered direct offering
Monday, 29 Aug 2016 11:07am EDT 

Ampio Pharmaceuticals Inc : Ampio Pharmaceuticals, Inc. announces pricing of registered direct offering . Entered into securities purchase agreement providing for registered sale of 5 million shares, warrants to purchase up to 5 million shares . Gross proceeds to company from offering will approximate $3.8 million .Says warrants are immediately exercisable and have a term of five years from date of issuance.  Full Article

Ampio launches clinical trial of ampion
Tuesday, 10 May 2016 08:50am EDT 

Ampio Pharmaceuticals Inc :Ampio launches clinical trial of ampion for the treatment of osteoarthritis of the hand.  Full Article

BRIEF-Ampio discloses receipt of notice from NYSE American

* Ampio discloses receipt of notice from NYSE American and has until March 1, 2019, to gain compliance Source text for Eikon: Further company coverage: